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AbsTrACT
Objectives to assess the effectiveness of an internet-
accessed Sti (e-Sti) testing and results service on testing 
uptake among young adults (16–30 years) who have 
never tested for Stis in london, england.
Methods We conducted secondary analyses on 
data from a randomised controlled trial. in the trial, 
participants were randomly allocated to receive a text 
message with the web link of an e-Sti testing and 
results service (intervention group) or a text message 
with the link of a website listing the locations, contact 
details and websites of seven local sexual health clinics 
(control group). We analysed a subsample of 528 trial 
participants who reported never testing for Stis at 
baseline. Outcomes were self-reported Sti testing at 6 
weeks, verified by patient record checks, and time from 
randomisation to completion of an Sti test.
results Uptake of Sti testing among ’never testers’ 
almost doubled. at 6 weeks, 45.3% of the intervention 
completed at least one test (chlamydia, gonorrhoea, 
syphilis and HiV), compared with 24.1% of the control 
(relative risk [rr] 1.88, 95% ci 1.47 to 2.40, p<0.001). 
For chlamydia and gonorrhoea testing combined, 
uptake was 44.3% in the intervention versus 24.1% in 
controls (rr 1.84, 95% ci 1.44 to 2.36, p<0.001). the 
intervention reduced time to any Sti test (restricted mean 
survival time: 29.0 days vs 36.3 days, p<0.001) at a time 
horizon of 42 days.
Conclusions  e-Sti testing increased uptake of 
Sti testing and reduced time to test among a young 
population of ’never testers’ recruited in community 
settings. although encouraging, questions remain on 
how best to manage the additional demand generated 
by e-Sti testing in a challenging funding environment. 
larger studies are required to assess the effects later in 
the cascade of care, including Sti diagnoses and cases 
treated.
InTrOduCTIOn
Testing coverage for STIs remains suboptimal 
in England. The National Chlamydia Screening 
Programme (NCSP) encourages sexually active 
young adults (15–24 years) to test annually for chla-
mydia and on change of sexual partner. Yet in 2017, 
only 20% of local authorities reached the recom-
mended chlamydia detection rate of at least 2300 
diagnoses per 100 000 population of individuals 
aged 15–24 years.1
Both psychosocial and contextual factors inhibit 
the use of face-to-face sexual health services.2 3 
Online sexual health services, including internet-ac-
cessed STI (e-STI) testing, may overcome some of 
these barriers by enabling users to bypass the stigma, 
embarrassment and inconvenience associated with 
face-to-face care.4–7 Typically, e-STI testing requires 
users to order postal self-sampling kits online, 
collect their own samples, return samples to a 
laboratory and be notified of their results by short 
message service text message or telephone.8 9
Public Health England recommends e-STI testing 
to expand access to opportunistic screening for 
chlamydia, particularly young adults who struggle 
to access conventional services, including young 
men and those in rural areas.9 Yet the evidence on 
the effectiveness of e-STI testing to increase testing 
uptake among those who do not use face-to-face 
STI testing pathways is extremely limited.
One randomised controlled trial (RCT) conducted 
with individuals aged 18–24 years in France 
provided data to suggest that among those who had 
never previously screened for chlamydia, a higher 
proportion of the intervention group (e-STI testing) 
completed a chlamydia test (28.2%, 1257/4453), 
compared with the control group allocated to usual 
care (7.5%, 331/4431). However, outcomes were 
assessed differently in the control and intervention 
arms, and it is not known whether participants 
tested for other STIs prior to the study.10
In 2015, we completed a large RCT in Lambeth 
and Southwark—two London boroughs with 
extremely high rates of STIs relative to London and 
the rest of England.11 We found that e-STI testing 
increased uptake of testing at 6 weeks among a 
young population (16–30 years), when offered in 
community settings and delivered alongside usual 
care (50.0% vs 26.6%, relative risk 1.87, 95% CI 
1.63 to 2.15, p<0.001).12 Here we examine the 
effect of e-STI testing on uptake of any STI test, 
uptake of chlamydia and gonorrhoea tests and time 
to test, among a subsample of trial participants who 
reported never having tested for an STI at baseline. 
In view of the distinct policy context and barriers 
associated with the provision of routine HIV 
testing outwith specialist settings in the UK, we will 
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report results for uptake of serological testing (including HIV) 
separately.
MeTHOds
study design
The trial procedures are described in detail elsewhere.12 Briefly, 
participants were recruited in community settings. The study was 
promoted alongside a health promotion message to encourage STI 
testing. Young people aged 16 –30 years of age, resident in the 
London boroughs of Lambeth and Southwark, sexually active (at 
least one sexual partner in the last 12 months), stated willingness 
to take an STI test and with access to the internet were eligible for 
inclusion.
At randomisation, participants in the intervention group were 
sent a text message with the uniform resource locator (URL) of 
SH:24 ( www. sh24. org. uk). SH:24 offered free postal self-sam-
pling test kits for chlamydia, gonorrhoea, HIV and syphilis. Chla-
mydia, gonorrhoea and syphilis test results were delivered by text 
message. Participants with reactive results for syphilis or positive 
results for chlamydia and gonorrhoea were signposted to local 
clinics for confirmatory testing and treatment as required. Reac-
tive results for HIV were communicated by phone by a clinician. 
Non-returners of test kits were sent a text message reminder at 2 
weeks. Additional information on the tests kits and procedures is 
provided in online supplementary file 1.
Participants in the control arm were sent the URL of a bespoke 
website with the contact details, websites and location (google map 
image) of seven sexual health clinics in Lambeth and Southwark. 
All participants were free to use any other services or interventions.
At 6 weeks, we collected self-reported data online or via a postal 
questionnaire. We obtained objective measures for our endpoints 
(uptake of STI testing, cases diagnosed and cases treated) by 
searching the SH:24 database and patient record databases at 
Hospital Trusts in Lambeth and Southwark for all participants. If 
participants reported using another service (general practitioner 
(GP) surgery or sexual health service outside the boroughs), we 
contacted the service to collect STI testing, diagnosis and treatment 
data.
In these secondary analyses, we analysed a subsample (n=528) 
of the main trial sample (n=2063) who reported never having had 
an STI test at baseline. Our outcomes are: (1) the proportion of 
participants who tested for any STI at 6 weeks from randomisation 
and (2) time from randomisation to completion of an STI test in 
each arm. In addition, we assessed the proportion of participants 
who tested for chlamydia and gonorrhoea (combined) at 6 weeks.
The process outcomes are the proportion who tested positive 
for any STI among participants who completed a test within 6 
weeks; the proportion of participants who completed an STI test 
by service type; and the proportion who consider the intervention 
to be acceptable (intervention group only).
statistical methods
In the main trial, 50.0% of the intervention group completed an 
STI test compared with 26.6% in the control group (RR 1.87, 95% 
CI 1.63 to 2.15, p<0.001).12 We hypothesised that in this subpop-
ulation, far fewer participants would complete an STI test in each 
arm but that the relative effect of e-STI testing on testing uptake 
would be similar. We assumed that 28% of the intervention group 
would complete a test compared with 15% in the control group. A 
sample size of 420 would lead to 90% power (two-side alpha=5%) 
to detect a relative risk of 1.87.
We adopted a similar statistical approach to the main trial anal-
yses for comparability. Randomisation was based on minimisation, 
which required an adjusted analysis to account for variables 
included in the algorithm.13 To obtain more precise estimates 
and CIs with the correct coverage, our analysis models used an 
inverse probability of treatment estimator to estimate the average 
treatment effect (ATE). In these models, the ATE is expressed as 
the weighted risk difference. Covariates included all minimisa-
tion factors (gender, age, sexual orientation and number of sexual 
partners in the last 12 months) in addition to ethnicity, as this is 
also a predictor of the outcome.14 Estimates for the weighted risk 
ratio and their 95% CIs were obtained via the delta method of 
transformation.
To account for missing outcome data, we used multivariate 
imputation by chained equations assuming data are missing at 
random (MAR). We imputed our two outcomes: (1) any STI test, 
(2) chlamydia and gonorrhoea tests, using two separate models. 
Each imputation model conditioned on self-reported testing and 
self-reported diagnoses, which were also incomplete. We included 
randomised group as a covariate, which was weighted by the 
inverse of the propensity score to ensure compatibility with our 
models for analysis. We generated 100 imputed datasets for each 
outcome, and inference proceeded via Rubin’s rules.15
All baseline characteristics were fully observed, except for sexual 
orientation. A missing category was therefore used. In the main 
trial, a sensitivity analysis was conducted to explore departures 
from MAR for our coprimary outcomes of STI testing and STI 
diagnoses. The results were similar to the estimates under MAR 
for all the scenarios we investigated.12 For the purposes of these 
secondary analyses, we considered our assumption that data are 
MAR to be valid.
To explore heterogeneity of the intervention effect on our 
outcome, we tested for interaction at a 5% level of significance to 
assess whether effectiveness varied by the following baseline char-
acteristics: gender (male, female); ethnicity (white, black/African/
Caribbean/black British, Asian/Asian British/all other groups); age 
(16-19, 20–24, 25–30 years); number of sexual partners in the last 
12 months (1, 2+), sexual orientation (men who have sex with 
men (MSM), other); index of multiple deprivation (linear) and 
recruitment source (face-to-face, online, other). These analyses 
were conducted in the complete cases under a MAR assumption 
using a log binomial model.
We used survival analysis to estimate the restricted mean survival 
time (RMST) from randomisation to completion of an STI test for 
each group. The RMST is a measure of average survival from base-
line to a specified time point and corresponds to the area under the 
survival curve up to that point.16 We set the time horizons to t*=6 
weeks (42 days), t*=2 weeks (14 days) and t*=one week (7 days) 
to investigate possible time dependency of the intervention among 
this subsample. We accounted for covariates by weighting on the 
inverse of the estimated propensity score.
All analyses were performed using Stata V.15.1 and R Studio 
V.3.5.0.
resulTs
Outcome data (STI testing) were available for 87% (213/244) of 
the intervention group and 79% (224/284) of the control group.
Baseline characteristics are presented in table 1.
At 6 weeks, 45.3% of the intervention completed at least one 
STI test, compared with 24.1% of the control group (RR 1.88, 
95% CI 1.47 to 2.40, p<0.001). For chlamydia and gonorrhoea 
testing combined, 44.3% completed a test in the intervention 
compared with 24.1% in the control (RR 1.84, 95% CI 1.44 to 
2.36, p<0.001) (table 2).
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Table 1 Baseline characteristics of participants
Intervention group 
(n=244)
Control group 
(n=284)
Gender
  Female 130 (53.3%) 142 (50.0%)
  Male 113 (46.3%) 141 (49.6%)
  Transgender 1 (<1%) 1 (<1%)
Mean age in years 21.3 (3.5) 21.3 (3.6)
Age group (years)
  16–19 96 (39.3%) 118 (41.5%)
  20–24 96 (39.3%) 110 (38.7%)
  25–30 52 (21.3%) 56 (19.7%)
sexual orientation
  MSM 14 (5.7%) 21 (7.4%)
  Other 224 (91.8%) 258 (90.8%)
  Refused 6 (2.5%) 5 (1.8%)
Partners in last 12 months
  1 111 (45.5%) 123 (43.3%)
  2 or more 133 (54.5%) 161 (56.7%)
ethnic group
  White/white British 176 (72.1%) 194 (68.3%)
  Black/black British 18 (7.4%) 25 (8.8%)
  Asian/Asian British 33 (13.5%) 34 (12.0%)
  Mixed/multiple ethnicity 14 (5.7%) 26 (9.2%)
  Other 3 (1.2%) 5 (1.8%)
Data are n (%) or mean (SD).
The sociodemographic characteristics of ‘never’ and ‘ever’ testers within the full 
RCT sample are presented in online supplementary file 2.
RCT, randomised controlled trial.
Table 2 Effect of the intervention on testing uptake at 6 weeks
Intervention Control 
risk difference relative risk
P value (95% CI) (95% CI)
Uptake of testing (any STI) at 6 weeks 45.3% 24.1% 21.2% (12.5 to 29.8) 1.88 (1.47 to 2.40) <0.001
Uptake of chlamydia and gonorrhoea testing at 6 weeks 44.3% 24.1% 20.2% (11.7 to 28.8) 1.84 (1.44 to 2.36) <0.001
Similar results were observed for the analyses in the complete cases (online supplementary file 3).
In the complete cases, the intervention reduced time to test 
for any STI at 42 days. A very small difference was observed at 
14 days but no difference at 7 days (table 3).
The intervention was more effective in those recruited via 
face-to-face settings, compared with those recruited online or 
via other methods (eg, print media). No heterogeneity was 
observed across any other subgroups (figure 1).
Process outcomes
Among those who completed a test, 4.3% (4/94) of the interven-
tion arm tested positive for an STI, compared with 2.3% (1/44) 
in the control. A percentage of 89.4 (84/94) of those who tested 
in the intervention arm tested via SH:24 (online supplementary 
file 4). A percentage of 75.0 (63/84) of the intervention arm who 
tested via SH:24 provided data on acceptability. Of those 74.6% 
(47/63) deemed the SH:24 pathway to be acceptable.
dIsCussIOn
statement of principal findings
When promoted in community settings and delivered alongside 
usual care, e-STI testing increases testing uptake among individuals 
who have never tested for STIs. Similar estimates were observed 
when we examined the effects on uptake of testing for chlamydia 
and gonorrhoea. The intervention reduced time to test.
strengths and weaknesses
The strengths of the main trial have been discussed elsewhere.12 In 
these secondary analyses, the outcomes of uptake of any STI test, 
and uptake of chlamydia and gonorrhoea testing combined, were 
known for 83% of participants. We collected objective outcome 
data including for those participants who tested outside of Lambeth 
and Southwark or via an alternative care pathway (eg, at their GP). 
Our subsample of ‘never testers’ included priority groups for STI 
prevention: 80% (420/528) were young adults between 16 years 
and 24 years and 7% (35/528) were MSM. In addition, over half 
(294/528) reported having at least two sexual partners in the last 
12 months.
Secondary analyses of RCT data are recommended to generate 
additional insights beyond the primary research question and to 
make efficient use of trial datasets.17 18 We specified our hypoth-
eses and obtained ethical approval prior to conducting these anal-
yses, and we had sufficient power to detect intervention effects on 
STI testing uptake. Selecting a subsample of randomised partic-
ipants for secondary analyses can introduce baseline imbalances. 
Our adjusted analyses, based on inverse probability of treatment 
weighting, accounted for possible imbalances across key prog-
nostic factors.
Our study has several limitations. It was not possible to assess 
outcomes later in the cascade of care such as STI diagnoses and 
STI cases treated due to insufficient power. Nevertheless, undi-
agnosed infections were detected in this subpopulation. Of those 
who tested, 4.3% (4/94) in the intervention arm and 2.3% (1/44) 
in the control arm were diagnosed with an STI. Four participants 
were diagnosed with chlamydia and one with gonorrhoea. This 
underlines the importance of public health strategies to reach 
populations who do not use conventional services.
Our subgroup analysis suggests that the effect of the intervention 
was greater among those recruited in face-to-face settings. A lower 
proportion of control participants recruited in face-to-face settings 
accepted the offer a test, compared with those recruited elsewhere. 
It is plausible that those recruited in face-to-face settings, such as 
further education colleges, had greater exposure to campaigns 
encouraging clinic-based testing and were therefore more ambiva-
lent towards the offer of a test in a face-to-face setting. However, 
these analyses were exploratory and further research is warranted.
Meaning and mechanisms
To our knowledge, this is the first study to assess the effectiveness 
of an e-STI testing service offered to young adults who had never 
previously tested for STIs.
Our findings may have implications for the way e-STI testing is 
promoted in routine settings. In 2017, only 10.1% of all chlamydia 
tests in England were conducted via internet-accessed services.1 
This may be indicative of patient preference, low availability of 
e-STI testing in some settings or data quality. It is also plausible 
that young people lack awareness of online care pathways. In our 
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Table 3 Time to test (any STI)
Intervention Control rMsT difference
P value rMsT (se) rMsT (se) (95% CI)
Time to test (t*=42 days) 29.0 (1.1) 36.3 (0.9) 7.3 days (4.5 to 10.1) <0.001
Time to test (t*=14 days) 12.2 (0.2) 12.9 (0.2) 0.7 days (0.1 to 1.3) 0.02
Time to test (t*=7 days) 6.8 (0.1) 6.7 (0.1) −0.1 days (−0.3 to 0.1) 0.21
RMST, restricted mean survival time.
Figure 1 Effect of the intervention on STI testing uptake by subgroup.
study, all intervention participants were sent the web link of SH:24 
via text message. Text messaging is an effective medium for sexual 
health promotion19 and could be used to promote e-STI testing in 
routine care.
The effect estimate for STI testing (relative risk) is comparable 
in magnitude to the effect size from the main trial analyses, and 
this was expected. The proportions of participants who completed 
a test in each arm are also comparable, but this was not antici-
pated. We had assumed that this subsample of ‘never testers’ would 
be more reluctant to accept the offer of a test. Our recruitment 
strategy, which included a health message to promote regular STI 
testing, may offer insights for interventions that aim to increase 
demand for testing in community settings.
The number of chlamydia cases (n=4) were too few to assess 
care pathways for those diagnosed by online and clinic services in 
this study. Results from a preliminary observational evaluation of 
an eSexual health clinic—offering web-based results, risk manage-
ment and remote treatment for chlamydia via pharmacy collec-
tion—suggest that online treatment pathways are feasible for users 
of e-STI testing services.20
In the intervention arm, 4.3% of completed chlamydia tests were 
positive. In routine settings, 9% of internet-accessed chlamydia 
tests reported to the NCSP were positive in 2017.1 In our study, 
those who chose to participate, and complete a test via SH:24, 
may have practised lower risk behaviours than young people who 
use e-STI testing in routine care. Despite this lower test positivity, 
it is encouraging that the intervention increased chlamydia testing 
among a sexually active population who were either eligible (<25 
years) or recently eligible (25–30 years) for opportunistic chla-
mydia screening but had never tested for chlamydia (or other STIs) 
in their lifetime.
The effect of the intervention is time dependent. There was 
a reduction in time to test at time horizons of 42 days but little 
or no difference at 14 and 7 days. While most participants in 
the intervention arm ordered the kits almost immediately after 
randomisation, they delayed in returning the kits to the labo-
ratory (median time from kit order to kit return=9 days (IQR 
7–13.5)). SH:24 sent reminder text messages at 2 weeks to all 
non-returners. Future iterations of e-STI testing services could 
reduce delays on the care pathway by sending earlier and more 
frequent reminders.
The barriers to seeking sexual healthcare are multifaceted and 
operate at individual and structural levels.2 21 It is encouraging that 
in the trial sample, those who tested previously were more likely to 
report multiple sexual partners in the past year and to identify as 
MSM, compared with never testers (online supplementary file 2). 
Higher proportions of never testers were male, of Asian or Asian 
British ethnicity and younger age (16–19 years), which is in line 
with other studies that have reported barriers to service use among 
these groups.9 22 23
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Key messages
 ► Internet-accessed STI (e-STI) testing is an effective measure 
to increase uptake of STI testing, including chlamydia testing, 
among young people who do not use conventional services
 ► The effect of e-STI testing on outcomes later in the cascade 
of care including cases diagnosed and treated requires 
further evaluation
 ► In this current funding environment, questions remain on 
how best to manage the additional demand generated by 
e-STI testing
Importantly, over half (~54%) of the intervention group did 
not complete a test, which suggests that e-health services do not 
circumvent all obstacles associated with face-to-face care. Further 
research is needed to understand the precise mechanism of change 
among this subpopulation of never testers and to identify persistent 
barriers to testing.
For some first-time testers, e-STI testing services may become 
their preferred point of contact with the sexual healthcare system. 
This presents commissioners and providers with the challenge of 
ensuring that the package of care attainable via face-to-face and 
online entry points is comparable. For young adults, this should 
include comprehensive sexual health information, safeguarding, 
access to condoms, contraception and signposting to additional 
services as required.24 Much will depend on the integration that 
can be achieved between online and face-to-face clinical pathways. 
This includes the capacity of online providers to identify vulner-
able users and those with complex health needs and to oversee 
their transition to face-to-face care.6 25
e-STI testing was initially positioned within a normative agenda 
to expand access to health services.4 In the wake of cuts to sexual 
health funding in England, e-STI testing is increasingly viewed 
as a means to meet existing demand for STI testing at reduced 
cost.26 27 In London, many genitourinary medicine clinics divert 
asymptomatic patients to online care, prioritising scarce resources 
for more complex cases. Yet, consistent with the findings of this 
study, and the main RCT,12 a study based on routine data found 
that the introduction of SH:24 increased basic STI testing activity 
across the whole system in Lambeth and Southwark.28 Meeting 
additional demand is challenging in this current funding climate, 
and has resulted in a daily cap on online orders in some areas.
The impact of demand management strategies on young adults 
seeking sexual healthcare in either face-to-face or online service 
environments remains unknown. Online services may not be 
appropriate for all asymptomatic cases, and some patients require 
additional support to use e-STI testing.28 Careful monitoring is 
required to determine if the benefits of e-STI testing observed in 
our research translate into similar benefits in routine settings.
COnClusIOns
This study has demonstrated that e-STI testing, delivered along-
side usual care, can increase STI testing uptake and reduce time-
to-test among a young population of ‘never testers’ recruited in 
community settings.
The findings lend weight to national guidance, which recom-
mends e-STI testing as a measure to expand access to opportun-
istic chlamydia screening. Yet questions remain on how best to 
manage the additional demand generated by e-STI testing in a 
challenging funding environment. e-STI testing services can be 
delivered to scale as demonstrated by SH:24 and other national 
online providers. e-STI testing requires ongoing monitoring and 
evaluation. Larger studies are needed to assess outcomes later 
in the cascade of care such as STI diagnoses and cases treated.29
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